1. Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients Attending the Diabetic Clinic of the University of Gondar Hospital, Northwest Ethiopia.
- Author
-
Tsegaw, Asamere, Alemu, Shitaye, Dessie, Abere, Patterson, Christopher C., Parry, Eldryd H. O., Phillips, David I. W., and Trimble, Elisabeth R.
- Subjects
AUDITING ,GLYCOSYLATED hemoglobin ,HYPERTENSION ,CATARACT ,ACADEMIC medical centers ,ACQUISITION of data methodology ,SLIT lamp microscopy ,TYPE 2 diabetes ,VISUAL acuity ,DESCRIPTIVE statistics ,CHI-squared test ,MEDICAL records ,DISEASE prevalence ,DIABETIC retinopathy ,BODY mass index - Abstract
Objective. To investigate the level of diabetic retinopathy in type 2 diabetes (T2DM) patients attending the University of Gondar Hospital (UGH) Diabetic Clinic, Northwest Ethiopia. Methods. An audit was carried out involving a total of 739 T2DM patients attending at the diabetic clinic of UGH. They represented approximately 90% and 50% of all T2DM patients under regular review at the urban and rural diabetic clinics of UGH, respectively. All were supervised by the same clinical team for a long period. Eye examinations were performed for visual acuity, cataract, and retinal changes (retinal photography and slit-lamp biomicroscopy). Body mass index (BMI) and HbA1c levels were measured. The presence or absence of hypertension was recorded. Results. Men constituted 41.5% of the group, the mean age at diagnosis of T2DM was 50.4 years, and 50.2% were hypertensive. The BMI was 25.0 ± 4.1 kg/m
2 , and HbA1c was 7.75 ± 1.63% (61.2 ± 17.8 mmol/mol) (mean ± SD, for BMI and HbA1c)). Severe visual impairment/blindness was reported in 10.6%, 15.2% had cataract, 16.0% had retinopathy, and 11.1% had maculopathy. The prevalence of retinopathy increased with time from diagnosis of T2DM (chi-square for trend, p < 0.001) and with increasing HbA1c level (chi-square for trend, p = 0.03). Conclusion. These results compare well with the most recent results in well-equipped, wealthier regions of the world and show the importance of stable healthcare infrastructure for chronic-disease management. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF